Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2013
11/27/2013CN103415302A Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
11/27/2013CN103409428A Aptamer and application in preparing medicine or product for treating leukaemia thereof
11/27/2013CN103408666A Humanized anti-AEG-1 single chain antibody and application thereof
11/27/2013CN103408652A Novel anti-HBV endogenous protein HNF1alpha and application thereof
11/27/2013CN103405787A Molecular targeted nucleic acid nano-medicament based on miR-141 (micro ribonucleic acid-141), preparation and application thereof
11/27/2013CN103405786A Application of antisense oligonucleotides sequence of NSMCE2 (Non SMC Element 2) in preparation of medicine for inhibiting growth of colorectal cancer cell
11/27/2013CN103405785A Use of gene GADD45 beta in preparation of drug for treating bladder cancer
11/27/2013CN103405784A Use of c-Fos gene in preparation of anti-cancer drugs
11/27/2013CN103405783A OX26/CTX-PL/pC27 compound and application of OX26/CTX-PL/pC27 compound in treating gliomas
11/27/2013CN103405774A Novel drug targeting delivery adjuvant
11/27/2013CN103405770A Application of CDK2 antagonist as differentiation therapy drug sensitizer
11/27/2013CN102676519B Micro ribonucleic acid (RNA) for inhibiting viral multiplication of porcine reproductive and respiratory syndrome and application thereof
11/27/2013CN102675471B Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
11/26/2013US8592567 Vaccines and immunotherapeutics using codon-optimized IL-15 and methods for using the same
11/26/2013US8592389 MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
11/26/2013US8592388 Targeting MicroRNAs for metabolic disorders
11/26/2013US8592387 Methods for treating or preventing heart damage with integrin-linked kinase (ILK) compositions
11/26/2013US8592384 Micro-RNA's that regulate muscle cells
11/26/2013US8592368 JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
11/26/2013US8592210 Polyarginine-modified liposome having nuclear entry ability
11/26/2013US8591879 Recombinant adenovirus vector having a reduced side effect
11/26/2013CA2718802C Recombinant nucleic acids comprising regions of ad6
11/26/2013CA2561565C Methods for repression of phospholamban gene and modulating cardiac contractility
11/26/2013CA2448971C Chimeric flavivirus vectors
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013WO2013173789A2 Antisense oligonucleotide compositions
11/21/2013WO2013173652A1 Compositions and methods for modulating gene expression
11/21/2013WO2013173647A1 Compositions and methods for modulating apoa1 and abca1 expression
11/21/2013WO2013173645A1 Compositions and methods for modulating utrn expression
11/21/2013WO2013173601A1 Compositions and methods for modulating bdnf expression
11/21/2013WO2013173512A2 High-transduction-efficiency raav vectors, compositions, and methods of use
11/21/2013WO2013173129A2 Treatment of amd using aav sflt-1
11/21/2013WO2013172358A1 Functional compound, molecular assembly containing functional compound, composition containing molecular assembly, kit, and use of molecular assembly, composition or kit
11/21/2013WO2013170748A1 Plants as functional microrna and/or functional sirna vehicles, preparation methods and uses thereof
11/21/2013WO2013170735A1 Method for treating and/or preventing lung injury
11/21/2013US20130312126 Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals
11/21/2013US20130310446 Mir-21 promoter driven targeted cancer therapy
11/21/2013US20130310271 Tuberculosis diagnostic test
11/21/2013US20130309767 Methods and compositions for enhancing the efficacy and specificity of rna silencing
11/21/2013US20130309290 Gamma-tocopherol therapy for restenosis prevention
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309231 Methods for using taci-immunoglobulin fusion proteins
11/21/2013US20130309171 Pre-targeted nanoparticle system and method for labeling biological particles
11/20/2013EP2664672A1 Modified iRNA agents
11/20/2013EP2663323A1 Methods targeting mir-128 for regulating cholesterol/lipid metabolism
11/20/2013EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use
11/20/2013EP1662004B1 Method of preparing a proliferation-regulated recombinant adenoviral vector, kit and vector
11/20/2013CN1989250B Tc-83-derived alphavirus vectors, particles and methods
11/20/2013CN1832956B Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/20/2013CN103403166A Novel hybrid promoter and recombinant vector comprising the same
11/20/2013CN103403151A Methods for enhancing the delivery of gene-transduced cells
11/20/2013CN103402535A Use of ICAM-1 for prevention or treatment of neurological diseases
11/20/2013CN103397052A Endothelial progenitor cell with highly-expressed human CXCR7 (C-X-C chemokine receptor 7) gene as well as preparation method and application of endothelial progenitor cell
11/20/2013CN103397031A siRNA compositions and methods for potently inhibiting viral infection
11/20/2013CN103396996A NK92 cell strain carrying TGF-betaRII and NKG2D genes, and preparation method and use thereof
11/20/2013CN103396975A Vector pSVK based hepatitis B therapeutic plasmid DNA vaccine fermentation production method, and special engineering bacterium and high-yield fermentation culture medium therefor
11/20/2013CN103396557A Multifunctional cationic polymer gene vector, and preparation method and application thereof
11/20/2013CN103396491A Monoclonal antibodies against human anti-mullerian hormone type II receptor (AMHR-II), and manufacturing method thereof and application
11/20/2013CN103396478A Recombinant N-glycosylated protein from procaryotic cell
11/20/2013CN103394099A Application of microRNA-26a in preparation of drug for prevention or treatment of pulmonary fibrosis
11/20/2013CN103394098A Application of expression vector of natural killer cell enhancement factor (NKEF) of turbot
11/20/2013CN103394097A Primers of transmissible gastroenteritis-porcine epidemic diarrhea combined vaccine and preparation method
11/20/2013CN103394096A Novel viral vector
11/20/2013CN103394079A Cancer vaccine composition
11/20/2013CN102895672B Composition for treating cancers and use thereof
11/20/2013CN102140471B Oligo-nucleic acid for suppressing tumor growth and application thereof
11/20/2013CN101703761B Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/19/2013US8586726 Tissue-specific MicroRNAs and compositions and uses thereof
11/19/2013US8586559 Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
11/19/2013US8586558 RAB3B for treatment and prevention of Parkinson's disease
11/19/2013US8586555 Immunomodulatory compositions, formulations, and methods for use thereof
11/19/2013US8586524 Modulators of pharmacological agents
11/19/2013US8586354 Adenoviruses, nucleic acids that code for the same and the use of said viruses
11/19/2013US8586317 Methods of diagnosing hypophosphatemic disorders
11/19/2013US8586023 Cell capable of expressing exogenous GITR ligand
11/19/2013US8586022 Light emitting microorganisms and cells for diagnosis and therapy of tumors
11/19/2013CA2496213C Metalloprotease activation of myostatin, and methods of modulating myostatin activity
11/19/2013CA2411694C Furin polypeptides with improved characteristics
11/19/2013CA2404890C Rna sequence-specific mediators of rna interference
11/19/2013CA2398083C Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
11/19/2013CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
11/14/2013WO2013170170A2 Compositions and methods for gene therapy
11/14/2013WO2013170146A1 Methods and compositions for modulating mir-204 activity
11/14/2013WO2013170089A2 Compositions and methods for assessing cardiovascular disease
11/14/2013WO2013170086A2 Formulations for the delivery of active ingredients
11/14/2013WO2013170071A1 Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations
11/14/2013WO2013170020A2 Determining prostate cancer recurrence using polymorphisms in angiogenesis-related genes
11/14/2013WO2013169929A1 Reducing immunogenicity of xenogeneic transplant tissues
11/14/2013WO2013169829A2 Method of treating cancer
11/14/2013WO2012161755A9 Antagonism of the vip signaling pathway
11/14/2013WO2012082470A8 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
11/14/2013US20130303597 Sdf-1 delivery for treating ischemic tissue
11/14/2013US20130303595 Compositions and Methods for Treating Glioblastoma GBM
11/14/2013US20130303592 Treatment of Cancer by Inhibition of IGFBPs and Clusterin
11/14/2013US20130303586 Oligonucleotide compositions with enhanced efficiency
11/14/2013US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor
11/14/2013US20130302806 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
11/14/2013US20130302426 Modalities for the treatment of degenerative diseases of the retina
11/14/2013US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 870